It seemed as though the fighting was over when seven of the world’s largest drug companies agreed on Nov. 3 to pay $1.17 billion to settle a class action stemming from a global plot to fix the price of bulk vitamins mixed into everything from breakfast cereal to animal feed. But among plaintiffs’ lawyers involved in the case, the infighting has actually just begun.

Among class actions, this one is unusual because all the class members are companies, many of them large corporations with brand names like Tyson Foods Inc. and Kellogg Co. About 100 companies may opt out of the settlement to pursue individual suits for more in damages.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]